Ofatumumab for Minimal Residual Disease (MRD) and Maintenance Therapy
Clinical trial NCT01258933 · TERMINATED
Trial details
- NCT number
- NCT01258933
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-06
- Primary completion
- 2024-10-18
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.